Sign in

You're signed outSign in or to get full access.

Randal Klein

Director at XBP Global Holdings
Board

About Randal T. Klein

Randal Klein (age 60) joined XBP’s Board on July 29, 2025, as part of the post‑restructuring reconstitution; he is a Senior Portfolio Manager at Avenue Capital Management II, L.P., and a National Association of Corporate Directors Board Leadership Fellow . He holds an MBA in finance from the Wharton School and a BS in aerospace engineering from the University of Virginia; prior roles include SVP at Lehman Brothers (restructuring advisory, M&A, sponsors) and engineering/marketing at Boeing . XBP Europe Holdings, Inc. simultaneously adopted its Amended Charter and changed its name to XBP Global Holdings, Inc. on the Effective Date (July 29, 2025) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Avenue Capital Management II, L.P.Senior Portfolio Manager2004–present Oversees U.S. Strategy team investments
Lehman BrothersSenior Vice PresidentPrior to 2004 Restructuring advisory, sponsors coverage, M&A, corporate finance
The Boeing CompanyAerospace engineer; sales/marketingPrior career start Engineering/market roles

External Roles

OrganizationRoleTenureCommittees/Impact
Amplify Energy CorpDirector (current/past) Not disclosedNot disclosed
MagnaChip SemiconductorDirector (current/past) Not disclosedNot disclosed
GenesisCare USA GroupDirector (current/past) Not disclosedNot disclosed
Gravity Oilfield ServicesDirector (current/past) Not disclosedNot disclosed
NextWave HoldcoDirector (current/past) Not disclosedNot disclosed
Selcom GroupDirector (current/past) Not disclosedNot disclosed
Chassix AutomotiveDirector (current/past) Not disclosedNot disclosed
Midstates PetroleumDirector (current/past) Not disclosedNot disclosed
American MediaDirector (current/past) Not disclosedNot disclosed

Board Governance

  • Committee assignments: post‑restructuring board expanded to seven and four creditor‑designated nominees (including Klein) were appointed; specific committee assignments for new directors were not disclosed in the 8‑K .
  • Pre‑restructuring committees comprised independent directors: Audit (Reynolds, Clark, Akins; Reynolds chair), Compensation (Reynolds, Clark, Akins; Clark chair), Nominating (Reynolds chair; Clark, Akins) .
  • Independence: prior board determined each director other than Par Chadha and Andrej Jonovic qualified as independent under Nasdaq rules; after the restructuring XBP is no longer a “controlled company” (majority independent board expected), but independence status of newly appointed directors, including Klein, is not explicitly stated; Klein’s Avenue affiliation should be evaluated in independence determinations .
  • Executive sessions: non‑management directors meet periodically in executive session without management .
  • Attendance: not disclosed in the proxy or 8‑K.

Fixed Compensation

XBP’s 2024 non‑employee director compensation policy (approved January 2024) sets the baseline for director pay; specific grants to Klein were not disclosed post‑appointment.

ComponentAmountNotes
Annual cash retainer$60,000 For board service
Annual equity award$140,000 Subject to stockholder adoption of 2024 Plan; plan later amended in July 2025
Audit Committee Chair$20,000 Committee service fees
Audit Committee Member$10,000 Committee service fees
Compensation Committee Chair$10,000 Committee service fees
Compensation Committee Member$5,000 Committee service fees
Nominating Committee Chair$8,000 Committee service fees
Nominating Committee Member$4,000 Committee service fees

Additional governance changes: stock plan amended to increase authorized shares (5,000,000 base; conditional to 10% of outstanding post‑restructuring), potentially affecting future director equity awards .

Performance Compensation

  • No performance‑based metrics tied to director compensation were disclosed; director equity is time‑based per policy, not linked to operational KPIs .
Performance MetricTarget/DefinitionApplicability
Performance‑based vesting for directorsNot disclosed No metrics disclosed

Other Directorships & Interlocks

  • Klein’s Avenue affiliation is notable given Avenue Capital’s expected post‑restructuring stake in XBP (~9.8% assuming warrant exercise), creating a shareholder‑director interlock that can influence board dynamics .
  • Other major holders: Gates Capital (~25.9%) and ETI (~27.1%, assuming warrant exercise) may affect governance and voting blocs .

Expertise & Qualifications

  • Distressed investing, restructuring and transaction execution experience (Avenue/Lehman) aligned with XBP’s post‑Chapter 11 capital structure needs .
  • Engineering and operations background (Boeing) plus NACD Board Leadership Fellow credential support oversight in technology‑enabled services .

Equity Ownership

Direct beneficial ownership by Klein was not disclosed; Avenue’s holdings provide indirect alignment.

Holder/LinkageShares/PercentNotes
Avenue Capital (funds)Expected 12,057,745–13,968,650 shares (range pre‑issuance expectation) Post‑restructuring stake ~9.8% assuming warrants; dispersed control (no single >50%)
ETI~27.1% assuming warrant exercise Received common stock and warrants under Plan
Gates Capital~25.9% Significant holder post‑restructuring
Shares outstanding post‑issuance117,516,255 Issued 81,799,821 shares under Plan

Ownership guidelines, pledging/hedging policies for directors were not disclosed; corporate governance guidelines and Code of Ethics are posted but without specific numeric ownership requirements in the proxy .

Governance Assessment

  • Strengths:

    • Board de‑staggering and move away from “controlled company” status; creditor‑designated additions bring restructuring and digital operations expertise .
    • Adoption of Shareholder Rights (“poison pill”) provides near‑term takeover defense during capital structure transition; term limited to 18 months .
    • Registration Rights Agreement establishes orderly liquidity path for new holders, with lock‑up coordination to support market stability .
  • Red flags / conflict considerations:

    • Avenue affiliation: Klein’s role at a significant shareholder (Avenue ~9.8%) presents potential related‑party influence; independence must be assessed under Nasdaq considering this relationship .
    • Creditor designation rights: four nominees, including Klein, were appointed via a one‑time creditor right; while appropriate in restructurings, this can shift board priorities toward creditor/shareholder blocs rather than minority investors .
    • Complex financing stack: high secured indebtedness and multiple creditor agreements increase governance demands on audit and risk oversight committees; BPA Group’s prior material weaknesses and going‑concern issues elevate oversight risk .
    • Anti‑takeover device (rights plan) may limit shareholders’ ability to realize takeover premiums, requiring clear board rationale and sunset monitoring .
  • Signals to watch:

    • Committee assignments for new directors (audit/compensation/nominating) and identification of Lead Independent Director once the board finalizes roles .
    • Any related‑party transactions or approvals involving Avenue/ETI/Gates; audit committee oversight of such items per charter .
    • Director equity grants under the amended stock plan and any changes in cash vs. equity mix for directors post‑restructuring .

Attendance rates, individual director equity grant details (dates, share counts), and insider trading activity for Klein were not disclosed in the proxy or 8‑K documents reviewed.